Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion type Assertion NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_head.
- NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion description "[In conclusion, the hypermethylation of RASSF1A or RUNX3 gene is therefore a useful biomarker to predict the prognosis in NSCLC, particularly RASSF1A due to SCCs and RUNX3 due to ACs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_provenance.
- NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion evidence source_evidence_literature NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_provenance.
- NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion SIO_000772 17606310 NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_provenance.
- NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion wasDerivedFrom befree-20150227 NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_provenance.
- NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_assertion wasGeneratedBy ECO_0000203 NP861629.RAqlxfwM9R7BJA_UcAg-hM6jPkbI2PMhiCkw4lvwq1Qd4130_provenance.